Catalyst Wire Dossier Catalyst Wire Dossier

Dextroamphetamine sulfate (HLD100)

dextroamphetamine sulfate · Ironshore Pharmaceuticals and Development, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dextroamphetamine sulfate (HLD100), covering 2021-07-19 to 2021-07-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD [Phase 2]

See pricing